Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10Q - ACORDA THERAPEUTICS INC | form10q063010.htm |
| EX-31.1 - EXHIBIT 31.1 - ACORDA THERAPEUTICS INC | exhibit31.htm |
| EX-31.2 - EXHIBIT 31.2 - ACORDA THERAPEUTICS INC | exhibit31cfo.htm |
| EX-32.1 - EXHIBIT 32.1 - ACORDA THERAPEUTICS INC | exhibit32ceo.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ACORDA THERAPEUTICS INC | Financial_Report.xls |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Acorda Therapeutics, Inc. (the “Company”) for the fiscal quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, David Lawrence, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: August 9, 2010
|
/s/DAVID LAWRENCE | |
|
David Lawrence
|
||
|
Chief Financial Officer
|
||
|
(Principal Financial Officer)
|
[A signed original of this written statement required by Section 906 has been provided to Acorda Therapeutics, Inc. and will be retained by Acorda Therapeutics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.]